Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $350.00 | 3 | 76.7% |
| Food and Beverage | $106.08 | 1 | 23.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| COMSORT, Inc | $350.00 | 3 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $106.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $100.00 | 1 | COMSORT, Inc ($100.00) |
| 2018 | $150.00 | 1 | COMSORT, Inc ($150.00) |
| 2017 | $206.08 | 2 | Janssen Scientific Affairs, LLC ($106.08) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2019 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2018 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2017 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), YONDELIS, ZYTIGA | Food and Beverage | In-kind items and services | $106.08 | General |
| Category: Oncology | ||||||
| 03/10/2017 | COMSORT, Inc | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $100.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 227 | 364 | $74,745 | $26,965 |
| 2022 | 6 | 269 | 414 | $83,193 | $29,927 |
| 2021 | 7 | 317 | 472 | $91,807 | $35,780 |
| 2020 | 6 | 332 | 474 | $80,006 | $23,425 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 108 | 227 | $46,535 | $16,716 | 35.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 29 | $8,033 | $3,282 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $6,762 | $2,370 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 37 | 44 | $6,160 | $2,198 | 35.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 16 | 19 | $3,895 | $1,316 | 33.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 24 | $3,360 | $1,083 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 115 | 231 | $47,355 | $16,413 | 34.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 26 | $7,202 | $3,211 | 44.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 23 | 26 | $5,330 | $2,189 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 42 | $5,880 | $2,187 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 18 | 18 | $5,796 | $1,996 | 34.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 23 | 26 | $5,330 | $1,628 | 30.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 18 | 21 | $2,940 | $1,197 | 40.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 21 | 24 | $3,360 | $1,106 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 99 | 207 | $42,435 | $16,688 | 39.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 61 | 66 | $13,530 | $5,318 | 39.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 60 | 84 | $11,760 | $4,671 | 39.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 20 | 31 | $8,587 | $3,989 | 46.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 47 | 54 | $7,560 | $2,327 | 30.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 15 | 15 | $4,830 | $1,711 | 35.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 15 | 15 | $3,105 | $1,076 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 80 | 160 | $32,800 | $9,245 | 28.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 76 | 95 | $13,300 | $4,083 | 30.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 72 | 102 | $14,280 | $3,927 | 27.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 45 | 55 | $11,275 | $3,763 | 33.4% |
About Dr. Debashish Misra, M.D
Dr. Debashish Misra, M.D is a Hematology & Oncology healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255363545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Debashish Misra, M.D has received a total of $456.08 in payments from pharmaceutical and medical device companies, with $100.00 received in 2019. These payments were reported across 4 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($350.00).
As a Medicare-enrolled provider, Misra has provided services to 1,145 Medicare beneficiaries, totaling 1,724 services with total Medicare billing of $116,097. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Cambridge, MA
- Active Since 07/07/2006
- Last Updated 11/28/2012
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1255363545
Products in Payments
- KEYTRUDA (Biological) $350.00
- DARZALEX (Biological) $106.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cambridge
Robert Fram, M.d, M.D
Hematology & Oncology — Payments: $159,285
Jeffrey Jones, M.d, M.D
Hematology & Oncology — Payments: $20,956
Iris Sheng, M.d, M.D
Hematology & Oncology — Payments: $847.19
Dr. Thomas Caughey, Md, MD
Hematology & Oncology — Payments: $420.08
Dr. Nabiel Alkhouri, M.d, M.D
Hematology & Oncology — Payments: $377.33
Anna Berkenblit, M.d, M.D
Hematology & Oncology — Payments: $67.56